NEW DELHI: Delhi headquartered ChrysCapital, India’s largest homegrown independent private equity (PE) firm, is negotiating with a number of potential buyers to sell its 11 per cent stake in Mankind Pharma. The likely buyers are all PE firms, including the Singapore government’s investment arm Temasek Holdings, General Atlantic, Actis and Advent International. ChrysCapital is looking for a valuation of over $200 million for its 11% holding, which if realized, with fetch a return of more than 8 times on the seven year old investment.
Help employers find you! Check out all the jobs and post your resume.
